FDA Clears Blood Test To Detect Signs Of Alzheimer's Disease

FDA Clears Blood Test To Detect Signs Of Alzheimer's Disease Federal regulators have cleared a blood test aimed at detecting signs of Alzheimer's disease. The Food and Drug Administration cleared a blood test known as Elecsys pTau-217 for people aged at least 55 who have shown signs of, or have been complaining of, cognitive decline, Roche announced on Aug. 24. The test, which can be used by primary care doctors and specialists, detects a biomarker called plasma phosphorylated t...

By Tyler Durden